Back to FEDERATED HERMES, INC. FEDERATED HERMES, INC.

GLPGGLPG
11 quarters

Position history for FEDERATED HERMES, INC.FEDERATED HERMES, INC.'s holdings in LAKEFRONT BIOTHERAPEUTICS NV

No. Federated Hermes exited its GLPG (Lakefront Biotherapeutics) position in Q2 2021. Its Q1 2021 13F listed 165,000 shares worth $12.7M. Federated Hermes already held GLPG in its Q4 2018 13F, the earliest on record, and held it in 10 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$154M

Total Shares Change

-1.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2021-Q2
Latest
Exited
0
-100.0%
$00.0%$70.14
0
2021-Q1
Unchanged
165,000
0.0%
$12.7M0.0%$76.44
0
2020-Q4
Decreased
165,000
-88.4%
$16.3M0.0%$99.82
0
2020-Q3
Increased
1.4M
+0.1%
$201.9M0.5%$141.75
36
2020-Q2
Increased
1.4M
+1.1%
$280.5M0.7%$196.55
44
2020-Q1
Decreased
1.4M
-8.5%
$275.6M0.8%$190.38
0
2019-Q4
Decreased
1.5M
-2.6%
$317.8M0.7%$208.60
0
2019-Q3
Decreased
1.6M
-6.5%
$241M0.6%$153.86
0
2019-Q2
Increased
1.7M
+0.6%
$217.7M0.5%$128.93
43
2019-Q1
Increased
1.7M
+0.0%
$197.8M0.5%$117.78
36
2018-Q4
First report
1.7M
-
$154M0.4%$88.45
0

Other major holders of GLPG: SANDS CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used